Literature DB >> 3711261

Clonidine suppression test for pheochromocytoma: examples of misleading results.

H C Taylor, D Mayes, A H Anton.   

Abstract

Baseline plasma norepinephrine (NE) and epinephrine (E) levels over 2000 pg/ml or failure to suppress to less than 500 pg/ml after oral clonidine have been considered diagnostic of the presence of a pheochromocytoma. We found a false negative clonidine suppression test in a patient with an asymptomatic ACTH-secreting pheochromocytoma who had minimally increased resting plasma NE and E values of 669 and 419 pg/ml, respectively. Clonidine suppression caused decreases at 2 and 3 h to 372 and 408 pg/ml, respectively. A positive test was found in a patient with repeatedly elevated baseline plasma NE and E concentrations; the two highest results were 2501 and 3022 pg/ml. Clonidine administration on five occasions failed to decrease plasma NE and E levels to less than 500 pg/ml. However, no pheochromocytoma was found by selective venous catheterization, two laparotomies, and, ultimately, postmortem examination. Diffuse infiltration of lymphoplasmacytic cells throughout sympathetic ganglia and adrenal medulla raise the possibility of a diffuse autoimmune disorder, resulting in excessive catecholamine production. These examples suggest that the clonidine suppression test does not always indicate the presence or absence of a pheochromocytoma.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3711261     DOI: 10.1210/jcem-63-1-238

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

Review 1.  Pheochromocytoma.

Authors:  P E Cryer
Journal:  West J Med       Date:  1992-04

2.  A pheochromocytoma with normal clonidine-suppression test: how difficult the biochemical diagnosis?

Authors:  Michelangelo Sartori; Alessandro Cosenzi; Elena Bernobich; Lorenzo A Calo; Giuseppe Bellini; Andrea Semplicini
Journal:  Intern Emerg Med       Date:  2008-02-09       Impact factor: 3.397

Review 3.  Diagnostic problems in pheochromocytoma.

Authors:  M Mannelli
Journal:  J Endocrinol Invest       Date:  1989-11       Impact factor: 4.256

4.  Phaeochromocytoma: a catecholamine and oxidative stress disorder.

Authors:  K Pacak
Journal:  Endocr Regul       Date:  2011-04

5.  Intraoperative localization of malignant pheochromocytoma by 123-I-metaiodobenzylguanidine single probe measurement.

Authors:  H Lehnert; P Weber; B Nägele-Wöhrle; M von Bülow; D Eissner; F Schweden; T Junginger; J Schrezenmeir; U Krause; J Beyer
Journal:  Klin Wochenschr       Date:  1988-01-15

6.  Measurement of urinary metanephrines to screen for pheochromocytoma in an unselected hospital referral population.

Authors:  Keith L Brain; Jonathan Kay; Brian Shine
Journal:  Clin Chem       Date:  2006-09-21       Impact factor: 8.327

7.  Evaluation of clonidine suppression and various provocation tests in the diagnosis of pheochromocytoma.

Authors:  H Koshida; I Miyamori; R Soma; T Matsubara; S Okamoto; M Ikeda; R Takeda
Journal:  J Endocrinol Invest       Date:  1990-11       Impact factor: 4.256

8.  Evaluation of the clonidine-suppression test in the diagnosis of pheochromocytoma.

Authors:  G Plewe; U Krause; U Cordes; J Beyer
Journal:  Klin Wochenschr       Date:  1988-09-01

9.  Clonidine-induced suppression of plasma catecholamines in states of adrenal medulla hyperfunction.

Authors:  M D Gross; B Shapiro; J C Sisson; A Zweifler
Journal:  J Endocrinol Invest       Date:  1987-08       Impact factor: 4.256

10.  Cervical pheochromocytoma: a rare localization and a difficult diagnosis.

Authors:  G Becker; F Jockenhövel; R Bauer; S Lederbogen; R Lange; D Reinwein
Journal:  J Endocrinol Invest       Date:  1992-11       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.